Behavioral and electroencephalographic manifestations of thioacetamide-induced encephalopathy in rats

Canadian Journal of Physiology and Pharmacology

Volumn 90, Issue 9, 2012, Pages 1219-1227

  Mladenović, Dušan ^a   Radosavljević, Tatjana ^a   Hrncić, Dragan ^a   Rašić Marković, Aleksandra ^a   Puškaš, Nela ^a   Maksić, Nebojša ^b   Djuric, Dragan ^a   Stanojlović, Olivera ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Behavioral tests; EEG; Encephalopathy; Liver failure; Mean power spectra; Rats; Thioacetamide

Indexed keywords

THIOACETAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUDITORY STARTLE REFLEX; BEHAVIOR DISORDER; BODY EQUILIBRIUM; CONTROLLED STUDY; CORNEA REFLEX; DOSE RESPONSE; ELECTROENCEPHALOGRAPHY; EXPLORATORY BEHAVIOR; GRASPING; HEPATIC ENCEPHALOPATHY; HISTOPATHOLOGY; HYPOREFLEXIA; MALE; MEDICAL DEVICE; MOTOR ACTIVITY; NONHUMAN; POWER SPECTRUM; PRIORITY JOURNAL; RAT; REFLEX; RIGHTING REFLEX; SCORING SYSTEM; STARTLE REFLEX; WITHDRAWAL REFLEX;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROENCEPHALOGRAPHY; HEPATIC ENCEPHALOPATHY; LIVER; MALE; RATS; RATS, WISTAR; THIOACETAMIDE;

EID: 84865440218     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/Y2012-088     Document Type: Article

References (50)

1. Ahboucha, S., and Butterworth, R.F. 2008. The neurosteroid system: implication in the pathophysiology of hepatic encephalopathy. Neurochem. Int. 52(4-5): 575-587. doi:10.1016/j.neuint.2007.05. 004. PMID:17610999.
2. Ahboucha, S., Desjardins, P., Chatauret, N., Pomier-Layrargues, G., and Butterworth, R.F. 2003. Normal coupling of brain benzodia-zepine and neurosteroid modulatory sites of the GABA-A receptor complex in human hepatic encephalopathy. Neurochem. Int. 43(6): 551-556. doi:10.1016/S0197-0186(03)00065-2. PMID:12820983.
3. Albrecht, J., and Jones, E.A. 1999. Hepatic encephalopathy: molecular mechanisms underlying the clinical syndrome. J. Neurol. Sci. 170(2): 138-146. doi:10.1016/S0022-510X(99) 00169-0. PMID:10617392.
4. Albrecht, J., Zielińska, M., and Norenberg, M.D. 2010. Glutamine as a mediator of ammonia neurotoxicity: a critical appraisal. Biochem. Pharmacol. 80(9): 1303-1308. doi:10.1016/j.bcp.2010. 07.024. PMID:20654582.
5. Amodio, P., Marchetti, P., Del Piccolo, F., De Tourtchaninoff, M., Varghese, P., Zuliani, C., et al. 1999. Spectral versus visual EEG analysis in mild hepatic encephalopathy. Clin. Neurophysiol. 110 (8): 1334-1344. doi:10.1016/S1388-2457(99)00076-0. PMID: 10454268.
6. Amodio, P., Pellegrini, A., Ubiali, E., Mathy, I., Del Piccolo, F., Orsato, R., et al. 2006. The EEG assessment of low-grade hepatic encephalopathy: Comparison of an artificial neural network-expert system (ANNES) based evaluation with visual EEG readings and EEG spectral analysis. Clin. Neurophysiol. 117(10): 2243-2251. doi:10.1016/j.clinph.2006.06.714. PMID:16931145.
7. Avraham, Y., Israeli, E., Gabbay, E., Okun, A., Zolotarev, O., Silberman, I., et al. 2006. Endocannabinoids affect neurological and cognitive function in thioacetamide-induced hepatic encephalopathy in mice. Neurobiol. Dis. 21(1): 237-245. doi:10.1016/j. nbd.2005.07.008. PMID:16102970.
8. Boy, C, Meyer, P.T., Kircheis, G, Holschbach, M.H., Herzog, H., Elmenhorst, D., et al. 2008. Cerebral A1 adenosine receptors (A1AR) in liver cirrhosis. Eur. J. Nucl. Med. Mol. Imaging, 35(3): 589-597. doi:10.1007/s00259-007-0586-z. PMID:18000666.
9. Butterworth, R.F. 2011. Hepatic encephalopathy: a central neuroin-flammatory disorder? Hepatology, 53(4): 1372-1376. doi:10. 1002/hep.24228. PMID:21480337.
10. Cauli, O., Rodrigo, R., Llansola, M., Montoliu, C, Monfort, P., Piedrafita, B., et al. 2009. Glutamatergic and gabaergic neurotransmission and neuronal circuits in hepatic encephalopathy. Metab. Brain Dis. 24(1): 69-80. doi:10.1007/s11011-008-9115-4. PMID:19085094.
11. de Lima, J.M., de Freitas, F.J., Amorim, R.N., Câmara, A.C., Batista, J.S., and Soto-Blanco, B. 2011. Clinical and pathological effects of Calotropis procera exposure in sheep and rats. Toxicon, 57(1): 183-185. doi:10.1016/j.toxicon.2010.11.007. PMID:21087619.
12. Dodd, PR., Thomas, G.J., Harper, C.G., and Kril, J.J. 1992. Amino acid neurotransmitter receptor changes in cerebral cortex in alcoholism: effect of cirrhosis of the liver. J. Neurochem. 59(4): 1506-1515. doi:10.1111/j.1471-4159.1992.tb08467.x. PMID: 1328522.
13. Frederick, R.T. 2011. Current concepts in the pathophysiology and management of hepatic encephalopathy. Gastroenterol. Hepatol. (N.Y.), 7(4): 222-233. PMID:21857820.
14. Gammal, S.H., and Jones, E.A. 1989. Hepatic encephalopathy. Med. Clin. North Am. 73(4): 793-813. PMID:2657263.
15. García-Ayllón, M.-S., Cauli, O., Silveyra, M.-X., Rodrigo, R., Candela, A., Compañ, A., et al. 2008. Brain cholinergic impairment in liver failure. Brain, 131(11): 2946-2956. doi:10. 1093/brain/awn209. PMID:18772221.
16. Geller, D., Gammal, S.H., Mullen, K.D., and Jones, E.A. 1988. An improved rat model of hepatic encephalopathy due to fulminant hepatic failure: The importance of supportive therapy. In Advances in ammonia metabolism and hepatic encephalopathy. Edited by P.B. Soeters, J.H.P. Wilson, A.J. Meijer, and E. Holm. Excerpta Medica, Amsterdam, Netherlands. pp. 213-217.
17. Guerit, J.M., Amantini, A., Fischer, C, Kaplan, P.W., Mecarelli, O., Schnitzler, A., et al. (Members of the ISHEN commission on Neurophysiological Investigations). 2009. Neurophysiological investigations of hepatic encephalopathy: ISHEN practice guidelines. Liver Int. 29(6): 789-796. doi:10.1111/j.1478-3231.2009. 02030.x. PMID:19638107.
18. Hrnčić, D., Rašić-Marković, A., Krstić, D., Macut, D., Djuric, D., and Stanojlović, O. 2010. The role of nitric oxide in homocysteine thiolactone-induced seizures in adult rats. Cell. Mol. Neurobiol. 30(2): 219-231. doi:10.1007/s10571-009-9444-9. PMID:19714460.
19. Hunter, G.R., and Young, G.B. 2010. Recovery of awareness after hyperacute hepatic encephalopathy with "flat" EEG, severe brain edema and deep coma. Neurocrit. Care, 13(2): 247-251. doi:10. 1007/s12028-010-9391-9. PMID:20568022.
20. Hunter, A.L., Holscher, M.A., and Neal, R.A. 1977. Thioacetamide-induced hepatic necrosis. I. Involvment of the mixed-function oxidase enzyme system. J. Pharmacol. Exp. Ther. 200(2): 439-448. PMID:839448.
21. Jalan, R., Shawcross, D., and Davies, N. 2003. The molecular pathogenesis of hepatic encephalopathy. Int. J. Biochem. Cell Biol. 35(8): 1175-1181. doi:10.1016/S1357-2725(02)00396-5. PMID: 12757755.
22. Kato, T., Ito, Y., Hosono, K., Suzuki, T., Tamaki, H., Minamino, T., et al. 2011. Vascular endothelial growth factor receptor-1 signaling promotes liver repair through restoration of liver microvasculature after acetaminophen hepatotoxicity. Toxicol. Sci. 120(1): 218-229. doi:10.1093/toxsci/kfq366. PMID:21135413.
23. Li, X.Q., Dong, L., Liu, Z.H., and Luo, J.Y. 2005. Expression of y-aminobutyric acid A receptor subunits a 1, P1, y2 mRNA in rats with hepatic encephalopathy. World J. Gastroenterol. 11(21): 3319-3322. PMID:15929193.
24. Méndez, M., Méndez-López, M., Lopez, L., Aller, M.A., Arias, J., and Arias, J.L. 2008a. Mammillary body alterations and spatial memory impairment in Wistar rats with thioacetamide-induced cirrhosis. Brain Res. 1233: 185-195. doi:10.1016/j.brainres.2008. 07.040. PMID:18703028.
25. Méndez, M., Méndez-López, M., Lopez, L., Aller, M.A., Árias, J., Cimadevilla, J.M., and Árias, J.L. 2008b. Spatial memory alterations in three models of hepatic encephalopathy. Behav. Brain Res. 188 (1): 32-40. doi:10.1016/j.bbr.2007.10.019. PMID:18063138.
26. Michalak, A., Rose, C, Buu, P.N.T., and Butterworth, R.F. 1998. Evidence for altered central noradrenergic function in experimental acute liver failure in the rat. Hepatology, 27(2): 362-368. doi:10.1002/hep.510270208. PMID:9462632.
27. Miranda, A.S., Rodrigues, D.H., Vieira, L.B., Lima, C.X., Rachid, M. A., Teixeira Vidigal, P.V., et al. 2010. A thioacetamide-induced hepatic encephalopathy model in C57BL/6 mice. a behavioral and neurochemical study. Arq. Neuropsiquiatr. 68(4): 597-602. doi:10. 1590/S0004-282X2010000400022. PMID:20730316.
28. Mladenović, D., Krstic, D., Colovic, M., Radosavljević, T., Rašić-Marković, A., Hrnčić, D., et al. 2012. Different sensitivity of various brain structures to thioacetamide-induced lipid peroxidation. Med. Chem. 8(1): 52-58. doi:10.2174/157340612799278603. PMID: 22420551.
29. Monfort, P., Muñoz, M.D., and Felipo, V. 2004. Hyperammonemia impairs long-term potentiation in hippocampus by altering the modulation cAMP-degrading phosphodiesterase by protein kinase G. Neurobiol. Dis. 15(1): 1-10. doi:10.1016/j.nbd.2003.09.008. PMID:14751765.
30. Montagnese, S., Biancardi, A., Schiff, S., Carraro, P., Carlà, V., Mannaioni, G, et al. 2011. Different biochemical correlates for different neuropsychiatric abnormalities in patients with cirrhosis. Hepatology, 53(2): 558-566. doi:10.1002/hep.24043. PMID: 21274876.
31. Mori, W., and Aoyama, H. 1983. Statistical study on fulminant liver disease in Japan. Appl. Pathol. 1(4): 209-222. PMID:6331839.
32. Norenberg, M.D. 1977. A light and electron microscopic study of experimental portal-systemic (ammonia) encephalopathy. Progression and reversal of the disorder. Lab. Invest. 36(6): 618-627. PMID:559221.
33. Norenberg, M.D. 1987. The role of astrocytes in hepatic encephalopathy. Neurochem. Pathol. 6(1-2): 13-33. doi:10.1007/ BF02833599. PMID:3306480.
34. Norenberg, M.D., Itzhak, Y., and Bender, A.S. 1997. The peripheral benzodiazepine receptor and neurosteroids in hepatic encephalopathy. Adv. Exp. Med. Biol. 420: 95-111. doi:10.1007/978-1-4615-5945-0_7. PMID:9286429.
35. Norton, N.S., McConnell, J.R., and Rodriguez-Sierra, J.F. 1997. Behavioral and physiological sex differences observed in an animal model of fulminant hepatic encephalopathy in the rat. Physiol. Behav. 62(5): 1113-1124. doi:10.1016/S0031-9384(97) 00267-9. PMID:9333208.
36. Olesen, S.S., Graversen, C, Hansen, T.M., Blauenfeldt, R.A., Hansen, J.B., Steimle, K., and Drewes, A.M. 2011. Spectral and dynamic electroencephalogram abnormalities are correlated to psychometric test performance in hepatic encephalopathy. Scand. J. Gastroenterol. 46(7-8): 988-996. doi:10.3109/00365521.2011. 579160. PMID:21612322.
37. Pallomero-Gallagher, N., Reifenberger, G, Kostopoulos, G, Kircheis, G, Häussinger, D., and Zilles, K. 2006. Neurotransmitter receptor alterations in hepatic encephalopathy, In Hepatic Encephalopathy and Nitrogen Metabolism. Edited by D. Häussinger, G. Kircheis, and F Schliess. Springer, Dordrecht, Netherlands. pp. 255-272.
38. Palomero-Gallagher, N, Bidmon, H.J., Cremer, M., Schleicher, A., Kircheis, G, Reifenberger, G, et al. 2009. Neurotransmitter receptor imbalances in motor cortex and basal ganglia in hepatic encephalopathy. Cell. Physiol. Biochem. 24(3-4): 291-306. doi:10.1159/000233254. PMID:19710544.
39. Porter, W.R., Gudzinowicz, M.J., and Neal, RA. 1979. Thioacetamide-induced hepatic necrosis. II. Pharmacokinetics of thioaceta-mide and thioacetamide-S-oxide in the rat. J. Pharmacol. Exp. Ther. 208(3): 386-391. PMID:430359.
40. Rahman, T.M., and Hodgson, H.J. 2000. Animal models of acute hepatic failure. Int. J. Exp. Pathol. 81(2): 145-157. doi:10.1046/j. 1365-2613.2000.00144.x. PMID:10762442.
41. Rama-Rao, K.V., Jayakumar, A.R., and Norenberg, M.D. 2003. Ammonia neurotoxicity: role of the mitochondrial permeability transition. Metab. Brain Dis. 18(2): 113-127. doi:10.1023/ A:1023858902184. PMID:12822830.
42. Rama Rao, K.V., Reddy, P.V., Tong, X., and Norenberg, M.D. 2010. Brain edema in acute liver failure: inhibition by L-histidine. Am. J. Pathol. 176(3): 1400-1408. doi:10.2353/ajpath.2010.090756. PMID:20075201.
43. Rodrigo, R., Erceg, S., and Felipo, V. 2005. Neurons exposed to ammonia reproduce the differential alteration in nitric oxide modulation of guanylate cyclase in the cerebellum and cortex of patients with liver cirrhosis. Neurobiol. Dis. 19(1-2): 150-161. doi:10.1016/j.nbd.2004.12.001. PMID:15837570.
44. Shawcross, D., and Jalan, R. 2005. The pathophysiologic basis of hepatic encephalopathy: central role for ammonia and inflammation. Cell. Mol. Life Sci. 62(19-20): 2295-2304. doi:10.1007/ s00018-005-5089-0. PMID:16158192.
45. Sinke, A.P., Jayakumar, A.R., Panickar, K.S., Moriyama, M., Reddy, P.V., and Norenberg, M.D. 2008. NFkappaB in the mechanism of ammonia-induced astrocyte swelling in culture. J. Neurochem. 106 (6): 2301-2311. PMID:18662246.
46. Stanojlović, O., Rašić-Marković, A., Hrnčić, D., Šušie, V., Macut, D., Radosavljević, T., and Djuric, D. 2009. Two types of seizures in homocysteine thiolactone-treated adult rats, behavioral and electroencephalographic study. Cell. Mol. Neurobiol. 29(3): 329-339. doi:10.1007/s10571-008-9324-8. PMID:18972205.
47. Suárez, I., Bodega, G, and Fernández, B. 2002. Glutamine synthetase in brain: effect of ammonia. Neurochem. Int. 41(2-3): 123-142. doi:10.1016/S0197-0186(02)00033-5. PMID:12020613.
48. Wesierska, M., Klinowska, H.D., Adamska, I., Fresko, I., Sadowska, J., and Albrecht, J. 2006. Cognitive flexibility but not cognitive coordination is affected in rats with toxic liver failure. Behav. Brain Res. 171(1): 70-77. doi:10.1016/j.bbr.2006.03.019. PMID:16624422.
49. Yang, M.C., Chang, C.P., and Lei, HY. 2010. Endothelial cells are damaged by autophagic induction before hepatocytes in Con A-induced acute hepatitis. Int. Immunol. 22(8): 661-670. doi:10. 1093/intimm/dxq050. PMID:20547544.
50. Zarros, A., Theocharis, S., Skandali, N, and Tsakiris, S. 2008. Effects of fulminant hepatic encephalopathy on the adult rat brain antioxidant status and the activities of acetylcholinesterase, (Na (+), K(+))- and Mg(2+)-ATPase: comparison of the enzymes' response to in vitro treatment with ammonia. Metab. Brain Dis. 23 (3): 255-264. doi:10.1007/s11011-008-9091-8. PMID:18665440.